This federal contract award, valued at $11,231.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product, with a completion date of November 29, 2024. This award is a delivery order, priced on a firm fixed-price basis. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $3,941.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of August 12, 2024.
Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has been awarded multiple federal contracts and...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $47,054.34 for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML to the DLA Troop Support Medical. The contract, which does not have a set-aside designation, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division. This contract is a firm-fixed-price order with a completion date of September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,792.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. This award is under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for AmerisourceBergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,096.95 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of November 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $14,474.89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract provides for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of September 9, 2024. This is a firm-fixed-price delivery order contract, which is not set aside. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple contracts by...
This federal contract award, valued at $1,323.60, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with an ultimate completion date of August 5, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This contract award is not associated with any set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,842.45 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of December 10, 2024.
AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,100.43 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,218.89 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical product. This award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...